Search results
3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge
InvestorPlace· 6 hours agoThis seems to be the case with pharmaceutical stocks. During the covid-19 pandemic, the pharma...
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 11 hours agoAstraZeneca AZN will report first-quarter 2024 results on Apr 25, before market open. In the last...
With 85% ownership, AstraZeneca PLC (LON:AZN) boasts of strong institutional backing
Simply Wall St. via Yahoo Finance· 1 day agoKey Insights Given the large stake in the stock by institutions,AstraZeneca's stock price might be...
AstraZeneca (AZN) to Release Earnings on Thursday
ETF DAILY NEWS· 23 hours agoAstraZeneca (NASDAQ:AZN – Get Free Report) will issue its quarterly earnings data before the market opens on Thursday, April 25th. Analysts expect the company to announce ...
Insights Into Astrazeneca (AZN) Q1: Wall Street Projections for Key Metrics
Zacks via Yahoo Finance· 1 day agoBeyond analysts' top -and-bottom-line estimates for Astrazeneca (AZN), evaluate projections for some...
Cetera Trust Company N.A Purchases Shares of 3,700 AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 2 days agoCetera Trust Company N.A purchased a new position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) during the fourth quarter, according to the company in its most recent ...
Astrazeneca plc ADR’s (AZN) Stock: A Long-Term Performance Analysis – News Heater
NewsHeater· 2 days agoThe stock of Astrazeneca plc ADR (AZN) has gone up by 2.02% for the week, with a 5.94% rise in the past month and a 4.44% rise in the past quarter. The volatility ratio for ...
Greenleaf Trust Sells 1,500 Shares of AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 3 days agoGreenleaf Trust trimmed its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 5.1% during the 4th quarter, according to its most recent Form 13F filing with ...
Zacks Research Weighs in on AstraZeneca PLC’s Q2 2025 Earnings (NASDAQ:AZN)
ETF DAILY NEWS· 5 days agoAstraZeneca PLC (NASDAQ:AZN – Free Report) – Equities research analysts at Zacks Research cut their Q2 2025 EPS estimates for shares of AstraZeneca in a ...
Astrazeneca (AZN) Could Be a Great Choice
Zacks via Yahoo Finance· 5 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it...